Icu Medical [ICUI] vs Avantor [AVTR] Detailed Stock Comparison
Icu Medical
NASDAQ
Loading...
Avantor
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Icu Medical wins in 7 metrics, Avantor wins in 12 metrics, with 0 ties. Avantor appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Icu Medical | Avantor | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -26.49 | 13.47 | Icu Medical |
| Price-to-Book Ratio | 1.58 | 1.57 | Avantor |
| Debt-to-Equity Ratio | 80.57 | 67.34 | Avantor |
| PEG Ratio | 18.65 | 12.40 | Avantor |
| EV/EBITDA | 13.27 | 11.96 | Avantor |
| Profit Margin (TTM) | -3.87% | 10.70% | Avantor |
| Operating Margin (TTM) | 4.89% | 8.21% | Avantor |
| EBITDA Margin (TTM) | 4.89% | 8.21% | Avantor |
| Return on Equity | -4.62% | 12.52% | Avantor |
| Return on Assets (TTM) | 1.79% | 3.53% | Avantor |
| Free Cash Flow (TTM) | $113.83M | $692.00M | Avantor |
| 1-Year Return | -0.34% | -46.09% | Icu Medical |
| Price-to-Sales Ratio (TTM) | 1.30 | 1.43 | Icu Medical |
| Enterprise Value | $4.44B | $13.32B | Avantor |
| EV/Revenue Ratio | 1.84 | 1.99 | Icu Medical |
| Gross Profit Margin (TTM) | 34.75% | 33.82% | Icu Medical |
| Revenue per Share (TTM) | $99 | $10 | Icu Medical |
| Earnings per Share (Diluted) | $-3.82 | $1.04 | Avantor |
| Beta (Stock Volatility) | 0.87 | 1.05 | Icu Medical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Icu Medical vs Avantor Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Icu Medical | -0.99% | -2.74% | -5.05% | -8.14% | -24.37% | -20.58% |
| Avantor | -1.50% | 1.47% | 2.53% | 6.24% | -37.89% | -34.91% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Icu Medical | -0.34% | -30.15% | -29.39% | 25.86% | 248.24% | 316.71% |
| Avantor | -46.09% | -51.66% | -36.32% | -4.83% | -4.83% | -4.83% |
Performance & Financial Health Analysis: Icu Medical vs Avantor
| Metric | ICUI | AVTR |
|---|---|---|
| Market Information | ||
| Market Cap | $3.13B | $9.55B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 164,567 | 12,162,150 |
| 90 Day Avg. Volume | 205,399 | 11,881,783 |
| Last Close | $125.47 | $13.80 |
| 52 Week Range | $117.92 - $196.26 | $11.82 - $28.00 |
| % from 52W High | -36.07% | -50.71% |
| All-Time High | $321.70 (Aug 06, 2018) | $44.37 (Sep 20, 2021) |
| % from All-Time High | -61.00% | -68.90% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | -0.06% |
| Quarterly Earnings Growth | 0.07% | 0.07% |
| Financial Health | ||
| Profit Margin (TTM) | -0.04% | 0.11% |
| Operating Margin (TTM) | 0.05% | 0.08% |
| Return on Equity (TTM) | -0.05% | 0.13% |
| Debt to Equity (MRQ) | 80.57 | 67.34 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $80.76 | $8.95 |
| Cash per Share (MRQ) | $12.11 | $0.46 |
| Operating Cash Flow (TTM) | $209.57M | $808.50M |
| Levered Free Cash Flow (TTM) | $77.29M | $751.08M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Icu Medical vs Avantor
| Metric | ICUI | AVTR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -26.49 | 13.47 |
| Forward P/E | 18.65 | 12.40 |
| PEG Ratio | 18.65 | 12.40 |
| Price to Sales (TTM) | 1.30 | 1.43 |
| Price to Book (MRQ) | 1.58 | 1.57 |
| Market Capitalization | ||
| Market Capitalization | $3.13B | $9.55B |
| Enterprise Value | $4.44B | $13.32B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.84 | 1.99 |
| Enterprise to EBITDA | 13.27 | 11.96 |
| Risk & Other Metrics | ||
| Beta | 0.87 | 1.05 |
| Book Value per Share (MRQ) | $80.76 | $8.95 |
Financial Statements Comparison: Icu Medical vs Avantor
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ICUI | AVTR |
|---|---|---|
| Revenue/Sales | $604.70M | $1.58B |
| Cost of Goods Sold | $394.59M | $1.05B |
| Gross Profit | $210.11M | $534.90M |
| Research & Development | $23.29M | N/A |
| Operating Income (EBIT) | $29.59M | $147.40M |
| EBITDA | $82.47M | $230.80M |
| Pre-Tax Income | $-10.91M | $85.70M |
| Income Tax | $4.57M | $21.20M |
| Net Income (Profit) | $-15.48M | $64.50M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ICUI | AVTR |
|---|---|---|
| Cash & Equivalents | $289.70M | $315.70M |
| Total Current Assets | $1.42B | $2.28B |
| Total Current Liabilities | $549.02M | $2.03B |
| Long-Term Debt | $1.54B | $3.28B |
| Total Shareholders Equity | $1.99B | $6.10B |
| Retained Earnings | $674.68M | $2.27B |
| Property, Plant & Equipment | $466.20M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ICUI | AVTR |
|---|---|---|
| Operating Cash Flow | $90.80M | $86.60M |
| Capital Expenditures | $-14.62M | N/A |
| Free Cash Flow | $34.47M | $81.30M |
| Debt Repayment | $-48.08M | $-31.30M |
| Common Stock Repurchase | N/A | $-4.90M |
Short Interest & Institutional Ownership Analysis
| Metric | ICUI | AVTR |
|---|---|---|
| Shares Short | 1.18M | 40.07M |
| Short Ratio | 5.25 | 3.41 |
| Short % of Float | 0.06% | 0.08% |
| Average Daily Volume (10 Day) | 164,567 | 12,162,150 |
| Average Daily Volume (90 Day) | 205,399 | 11,881,783 |
| Shares Outstanding | 24.52M | 680.80M |
| Float Shares | 23.85M | 663.90M |
| % Held by Insiders | 0.03% | 0.01% |
| % Held by Institutions | 1.01% | 1.03% |
Dividend Analysis & Yield Comparison: Icu Medical vs Avantor
| Metric | ICUI | AVTR |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |